The Pim Kinase Inhibitor AZD1208 Enhances Apoptosis Induction By Clinically Active FLT3 Inhibitors in FLT3-ITD Acute Myeloid Leukemia Cells in Vitro and in Vivo through Synergistic Downregulation of Mcl-1 and of Bcl-xL

MLA

Rossana Trotta, et al. “The Pim Kinase Inhibitor AZD1208 Enhances Apoptosis Induction By Clinically Active FLT3 Inhibitors in FLT3-ITD Acute Myeloid Leukemia Cells in Vitro and in Vivo through Synergistic Downregulation of Mcl-1 and of Bcl-XL.” Blood, vol. 124, Dec. 2014, p. 3601. EBSCOhost, https://doi.org/10.1182/blood.v124.21.3601.3601.

APA

Rossana Trotta, Dennis Huszar, Trevor J. Mathias, Danilo Perrotti, Adriana E. Tron, Maria R. Baer, Manfred Kraus, Karthika Natarajan, & Kshama A. Doshi. (2014). The Pim Kinase Inhibitor AZD1208 Enhances Apoptosis Induction By Clinically Active FLT3 Inhibitors in FLT3-ITD Acute Myeloid Leukemia Cells in Vitro and in Vivo through Synergistic Downregulation of Mcl-1 and of Bcl-xL. Blood, 124, 3601. https://doi.org/10.1182/blood.v124.21.3601.3601

Chicago

Rossana Trotta, Dennis Huszar, Trevor J. Mathias, Danilo Perrotti, Adriana E. Tron, Maria R. Baer, Manfred Kraus, Karthika Natarajan, and Kshama A. Doshi. 2014. “The Pim Kinase Inhibitor AZD1208 Enhances Apoptosis Induction By Clinically Active FLT3 Inhibitors in FLT3-ITD Acute Myeloid Leukemia Cells in Vitro and in Vivo through Synergistic Downregulation of Mcl-1 and of Bcl-XL.” Blood 124 (December): 3601. doi:10.1182/blood.v124.21.3601.3601.